ClinVar Miner

Submissions for variant NM_000335.5(SCN5A):c.2542A>T (p.Ile848Phe)

gnomAD frequency: 0.00001  dbSNP: rs199473166
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000766791 SCV000235410 uncertain significance not provided 2024-05-09 criteria provided, single submitter clinical testing Has been reported in association with LQTS (PMID: 19716085); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34930020, 25904541, 19716085)
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000183004 SCV000540282 uncertain significance not specified 2016-06-23 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Only 1 report; ClinVar: P by GeneDx and Royal Brompton
Labcorp Genetics (formerly Invitae), Labcorp RCV000766791 SCV000545035 uncertain significance not provided 2024-09-27 criteria provided, single submitter clinical testing This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 848 of the SCN5A protein (p.Ile848Phe). This variant is present in population databases (rs199473166, gnomAD 0.0009%). This missense change has been observed in individual(s) with long QT syndrome (LQTS) and referred for LQTS testing (PMID: 19716085, 25904541, 34930020). ClinVar contains an entry for this variant (Variation ID: 67740). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN5A function (PMID: 34930020). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Color Diagnostics, LLC DBA Color Health RCV001842316 SCV001357910 uncertain significance Cardiac arrhythmia 2023-03-24 criteria provided, single submitter clinical testing This missense variant replaces isoleucine with phenylalanine at codon 848 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant causes a reduction in channel peak current density when expressed in HEK293 cells (PMID: 34930020). This variant has been reported in individual(s) suspected of having long QT syndrome (PMID: 19716085, 25904541) and in an individual moderately affected with atrial fibrillation, sick sinus syndrome, and premature ventricular contractions (PMID: 34930020). This variant has been identified in 1/251426 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
AiLife Diagnostics, AiLife Diagnostics RCV000766791 SCV002503359 uncertain significance not provided 2021-07-30 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV001842316 SCV004819873 uncertain significance Cardiac arrhythmia 2023-12-01 criteria provided, single submitter clinical testing This missense variant replaces isoleucine with phenylalanine at codon 848 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant causes a reduction in channel peak current density when expressed in HEK293 cells (PMID: 34930020). This variant has been reported in individual(s) suspected of having long QT syndrome (PMID: 19716085, 25904541) and in an individual moderately affected with atrial fibrillation, sick sinus syndrome, and premature ventricular contractions (PMID: 34930020). This variant has been identified in 1/251426 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000183004 SCV005422624 uncertain significance not specified 2024-10-21 criteria provided, single submitter clinical testing Variant summary: SCN5A c.2542A>T (p.Ile848Phe) results in a non-conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.9e-06 in 254026 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2542A>T has been reported in the literature in individuals affected with Long QT Syndrome (Kapplinger_2009, Glazer_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Long QT Syndrome. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in mild loss of function (>70% reduction of normal activity) in an in vitro assay (Glazer_2022). ClinVar contains an entry for this variant (Variation ID: 67740). Based on the evidence outlined above, the variant was classified as uncertain significance.
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust RCV000058509 SCV000090029 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.